NFAT-133
NFAT-133 is an aromatic polyketide with immunosuppressive and antidiabetic activity. NFAT-133 activates the AMPK pathway, promoting glucose uptake in L6 muscle fibers, thereby resisting diabetes. NFAT-133 inhibits the transcriptional activity of activated T-cell nuclear factor (NFAT), thereby suppressing the expression of IL-2 and the proliferation of T cells, demonstrating an immunosuppressive effect. NFAT-133 does not exhibit antibacterial activity or cytotoxicity, but it can weaken the production of NO in RAW264.7 cells induced by Lipopolysaccharide (LPS) (HY-D1056).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 165133-85-7
- 分子式: C17H24O3
- 分子量:276.37
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
AMPK |
IL-2 |
NFAT-133 (0.01-100 μM, 0.5-24 h) stimulates glucose uptake in a dose- and time-dependent manner, with an EC₅₀ value of 1.5 μM in rat L6 myotubes and has low cytotoxicity[2].
NFAT-133 (3 μM, 16 h) activates the AMPK-ACC signaling axis and ultimately promotes the translocation of GLUT4 to the cell membrane by phosphorylating AS160 in rat L6 myotubes (its mechanism of action is independent of the insulin signaling pathway (PI3K/Akt))[2].
NFAT-133 (0-50 μM) is inactive against Staphylococcus aureus ATCC 12600, Bacillus subtilis ATCC 6051, Escherichia coli ATCC 11775, and Pseudomonas aeruginosa ATCC 9721 and does not show any cytotoxicity towards RAW264.7, HeLa, NCI-H460 and MCF-7 cells[3].
NFAT-133 (25 h) weakly reduced the production of LPS-induced nitric oxide (NO) in RAW264.7 cells in a dose-dependent manner[3].
NFAT-133 (100 μM) fails to activate PPARγin rat L6 myotubes, thereby avoiding side effects such as weight gain, liver toxicity and cardiovascular risks[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Rat L6 myotubes
-
Concentration:3 μM
-
Incubation Time:16 h
-
Result:Stimulated AMPK activation but Akt.
Mediated AMPK activation did not affect CAMKKβ and LKB1.
Promoted AS160 phosphorylation and GLUT4 translocation.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Diabetes model established in l male db/db mice (7-9 weeks of age)[1]
-
Dosage:100 mg/kg
-
Administration:Intraperitoneal injection (i.p.), twice daily for 10 days
-
Result:Significantly reduced blood sugar and insulin levels without increasing the weight of the liver or the body weight of the mice.
化学情報
-
CAS 番号 165133-85-7
-
分子量 276.37
-
分子式 C17H24O3
-
SMILES
CC([C@@H](C)[C@H](O)[C@H](C1=C(C=C(C=C1)C)/C=C/CO)C)=O
-
Structure Classification
-
Initial Source
Dactylosporangium
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Yang Y, et al. Absolute configuration of NFAT-133, an aromatic polyketide with immunosuppressive and antidiabetic activity from actinomycetes. J Antibiot (Tokyo). 2016 Jan;69(1):69-71. [Content Brief]
[2]. Thakkar CS, et al. NFAT-133 increases glucose uptake in L6 myotubes by activating AMPK pathway. Eur J Pharmacol. 2015 Dec 15;769:117-26. [Content Brief]
[3]. Zhou W, et al. Identification and Biological Activity of NFAT-133 Congeners from Streptomyces pactum. J Nat Prod. 2021 Sep 24;84(9):2411-2419. [Content Brief]
[4]. Kulkarni-Almeida AA, et al. Fermentation, Isolation, Structure, and antidiabetic activity of NFAT-133 produced by Streptomyces strain PM0324667. AMB Express. 2011 Nov 21;1(1):42. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
NFAT-133 関連分類
HY-N16431 関連分類
Powered by Bioz